← Leaderboards
Kristin R Brogaard
Inherent Biosciences, Inc.
$2,141,752
Attributed
$2,141,752
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $854.7K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,141,752 · 2
By mechanism
R44$1,886,508 · 1
R43$255,244 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Reproductive Medicine”
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
- Michael E. Roth · Public Health Institute$8,303,012
- Timothy O'Connor · Rockefeller University$7,019,416
- Kevin Whaley · Boston University Medical Campus$3,612,638
- Sarah N Cilvik · Wake Forest University Health Sciences$2,943,331
- Yi Zheng · University Of Michigan At Ann Arbor$2,043,430
Research focus
Reproductive MedicineEpigenetic ProcessInfertilityProductionSperm CellY Chromosome MicrodeletionsGeneticGenetic TestingLaboratoriesMalignant NeoplasmsSamplingSmall Business Innovation Research GrantFailureS SyndromeBiological SciencesDiagnosisCollaborationsCommercializationDiagnostic TestsKlinefelter&AposMaleMale InfertilityChronicChild
Grant awards (5)
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility$804,660
R44 · FY2025 · HD · contact PI
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility$50,000
R44 · FY2025 · HD · contact PI
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility$762,166
R44 · FY2024 · HD · contact PI
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility$269,682
R44 · FY2023 · HD · contact PI
Clinical epigenetic diagnostic for spermatogenic failure and future health risks$255,244
R43 · FY2022 · HD · contact PI